Medrad goes direct in Brazil

Article

Indianola, PA-based Medrad is changing its Brazilian office to a direct sales and service operation. This will give Brazilian hospitals and medical imaging centers direct access to Medrad sales, service, and product application specialists. The office

Indianola, PA-based Medrad is changing its Brazilian office to a direct sales and service operation. This will give Brazilian hospitals and medical imaging centers direct access to Medrad sales, service, and product application specialists. The office has also been relocated to Sao Paulo from Curitiba. Staff size will double. Medrad has sold its products through distributors since entering the Brazilian market in 1977. Sales there have quadrupled since 1994.

Recent Videos
Nina Kottler, MD, MS
Related Content
FDA Clears Emerging Digital Tomosynthesis System

FDA Clears Emerging Digital Tomosynthesis System

Jeff Hall
April 17th 2025
Article

The Nanox.ARC X system reportedly provides enhanced 3D imaging for a variety of indications, ranging from pulmonary imaging and intra-abdominal views to musculoskeletal assessment.

Current Trends in X-ray Imaging

Current Trends in X-ray Imaging

Whitney J. Palmer
May 19th 2021
Podcast

KA Imaging President and Chief Executive Officer Amol Karnick and Chief Technology Officer Karim S. Karim, Ph.D., offer insights into current X-ray imaging trends, as well as opportunities for innovation.

Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims

Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims

Jeff Hall
April 3rd 2025
Article

In a review of over 1,630,000 office-based non-breast imaging Medicare fee-for-service (FFS) claims from 2022, researchers found that 39.5 percent of nuclear medicine imaging were interpreted by ordering clinicians.

FDA Clears AZchest AI Software for New CXR Applications

FDA Clears AZchest AI Software for New CXR Applications

Jeff Hall
March 31st 2025
Article

The AI-powered AZchest CXR software reportedly offers 93.79 percent sensitivity and a 98.57 percent AUC for pneumothorax.

FDA Clears Gleamer’s ChestView AI Software for CXR

FDA Clears Gleamer’s ChestView AI Software for CXR

Jeff Hall
March 25th 2025
Article

Adjunctive use of the AI-powered software led to an average 38.6 percent increase in the detection of pneumothorax by general radiologists, according to a 2023 study.

FDA Approves Glucagon Agent as Diagnostic Aid for Abdominal X-Rays

FDA Approves Glucagon Agent as Diagnostic Aid for Abdominal X-Rays

Jeff Hall
March 17th 2025
Article

Indicated for IV use, Gvoke VialDx reportedly inhibits movement of the gastrointestinal tract temporarily to facilitate abdominal X-rays.

© 2025 MJH Life Sciences

All rights reserved.